• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Hair Loss Remedies—Separating Fact From Fiction
Hair Loss Remedies—Separating Fact From Fiction

... of finasteride versus placebo in men aged 18 to 41 years with both vertex and frontal hair thinning showed that patients who took finasteride 1 mg/d for one year had significantly increased scalp coverage and hair counts than patients taking placebo.19,21,22 With continuous treatment of finasteride ...
Trends in Retail Prices of Brand Name Prescription Drugs
Trends in Retail Prices of Brand Name Prescription Drugs



... pharmacy only medicine under the supervision of a pharmacist. Cetirizine Dihydrochloride 10 mg Film-Coated Tablets (PL 33410/0062) is available as a GSL product and is sold without the supervision of a pharmacist in pack sizes of no greater than 14 tablets. Cetirizine Dihydrochloride 10mg Film-Coate ...
Methods of Drug Interaction Studies This document is an informal
Methods of Drug Interaction Studies This document is an informal

... drug and thereby increase the plasma concentration of its unbound form. In most cases, however, displacement does not result in a clinically significant change. Cases where displacement from plasma proteins causes increases in the plasma concentration of the unbound form of an investigational drug, ...
oral controlled release drug delivery system
oral controlled release drug delivery system

... Additional drug will enter the polymer, diffuse to the periphery and exchange with the surrounding media. The drug release takes place by diffusion mechanism. The diffusion type reservoir system is shown in figure 4. Advantages · Zero order delivery is possible. · Release rates can be modified with ...
Guideline on Inhalational medicinal products
Guideline on Inhalational medicinal products

... For non-compendial plastic and for rubber container closure components that are in contact with the formulation during storage (e.g., valves), a study should be conducted to determine the extractables profile. Details and justification of the study design (e.g., solvents used, temperature, storage t ...
Sustained release drug delivery system
Sustained release drug delivery system

... action tablet are an alternative method of sustained release in which multiple doses of drug are an alternative method of sustained release, in which, multiple doses are contained within a dosage form and each dose is released at a periodic interval. Delayed release system, in contrast, may not be s ...
Large-Scale Elucidation of Drug Response Pathways in Humans
Large-Scale Elucidation of Drug Response Pathways in Humans

... approach consists of two phases: (i) construction of drug-specific subnetworks by integrating protein interactions with drug-response gene expression data; and (ii) a meta-analysis of the inferred drug-response subnetworks to elucidate probable signaling pathways that are supported by multiple subne ...
Quality Assurance and Quality Control of 18 F-FDG
Quality Assurance and Quality Control of 18 F-FDG

... manufacturing practice to ensure that the drug meets the requirements of the act as to safety and has the identity and strength, and meets the quality and purity characteristics, that it purports or is represented to posses. In the clinical application of PET radiopharmaceuticals, it is essentially ...
PHYSICOCHEMICAL CHARACTERIZATION AND IN-VITRO DISSOLUTION BEHAVIOR OF GLICLAZIDE –SOLUPLUS SOLID DISPERSIONS
PHYSICOCHEMICAL CHARACTERIZATION AND IN-VITRO DISSOLUTION BEHAVIOR OF GLICLAZIDE –SOLUPLUS SOLID DISPERSIONS

... humidity, photo-stability, compatibility with solvents etc. Among all these, Solubility is the most important property for developing formulations. The present study is an attempt to improve the solubility and dissolution rate using solid dispersion of a poorly soluble drug Gliclazide by using Solup ...
Prediction of pharmacokinetic properties using experimental
Prediction of pharmacokinetic properties using experimental

... Thus, the half-life of any drug is a function of blood and tissue binding of the drug as well as its total clearance and is a derived parameter from Cls and V. For drugs with high clearance, the half-life is relatively independent of changes in intrinsic clearance, whereas for drugs with low clearan ...
Cephalexin Product Information Australia DRAFT
Cephalexin Product Information Australia DRAFT

pH TRIGGERED DRUG DELIVERY OF ORNIDAZOLE FROM EUDRAGIT COATED CHITOSAN MICROSPHERE:
pH TRIGGERED DRUG DELIVERY OF ORNIDAZOLE FROM EUDRAGIT COATED CHITOSAN MICROSPHERE:

... methacrylate etc. The idea behind Microspheres forColon specific drug delivery system is intended because it may reduce the Systemic side effect because of low dose of the drug. The absorption of the poorly absorbed drug is increase because of increase retention time in the colon1, 2. Ornidazole is ...
Iboga and Ibogaine - From Forest to Lab
Iboga and Ibogaine - From Forest to Lab

... In 2004, in support of clinical studies NIDA makes available a Drug Master File (DMF) provided to FDA comprising 16 volumes of data of ...
Successful cases of Traceability in the Healthcare Sector in
Successful cases of Traceability in the Healthcare Sector in

... managed by ANMAT, in order to guarantee that the drug has never abandoned the legal trail of production and distribution. As each package has an inviolable and incorruptible code, the patient can check that the product that he consumes has followed the right track, which gives the patient the assura ...
) PCH
) PCH

... psoriasis, and adult rheumatoid arthritis, Methotrexate inhibits dihydrofolic acid reductase. Dihydrofolates must be reduced to tetrahydrofolates by this enzyme before they can be utilized as carriers of one-carbon groups in the synthesis of purine nucleotides and thymidylate. Therefore, methotrexat ...
role of the liver and gut in systemic diphenhydramine clearance in
role of the liver and gut in systemic diphenhydramine clearance in

(Received on 27 /7/2005) (Accepted for publication on 29/4 /2006)
(Received on 27 /7/2005) (Accepted for publication on 29/4 /2006)

... benzene sulfonate , its empirical formula C20H25 Cl N2 O5 C6 H6 O3 S. It is one of the most widely used drugs for the management of essential hypertension. In this study an accurate and sensitive reversed phase liquid chromatographic method was adopted on deactivated ODS column using tetrahydrofuran ...


... showed a peak at the temperature corresponding to simvastatin melting point as shown in fig.4 but with the loss of its sharp appearance may be due to reduced drug crystallinity or may be due to combined melting points of drug and the components of microspheres . It confirmed that there was no intera ...
OVERVIEW
OVERVIEW

... The formation of the drug- receptor complex leads to a biological response. The magnitude of the response is proportional to the number of drug-receptor complexes. Intrinsic activity (Efficacy) Activation of the Molecular Target However, practitioners found two drugs that have equal affinities (bind ...
Preservative-Free Ophthalmic Products - Scope e
Preservative-Free Ophthalmic Products - Scope e

... Unlike most medications of other specialties, many ophthalmic products with preservatives are topical. But, exposure to preservatives is a major reason for the development of adverse effects as they have a potential to cause toxicity to the ocular surface, especially in the long-term therapies. Cont ...
Pharmacy Council of India
Pharmacy Council of India

... Mathematics individually also. ii) Candidates who have passed D.Pharm course from institutions approved by Pharmacy Council of India U/S 12 of Pharmacy Act, 1948, are only eligible to be admitted to first year Pharm. D course. ...
Determination of an Optimal Dosing Regimen for Fexinidazole, a
Determination of an Optimal Dosing Regimen for Fexinidazole, a

... behavioural changes and convulsions that, without treatment, progress to coma and eventually death. Coordinated efforts to control the disease have resulted in a sustained decrease in the number of cases over the last 10 years, down to 10,000 new cases in 2010. Sub-Saharan Africa remains the worst a ...
Date: March 7, 2007 Docket # 2006P-0535
Date: March 7, 2007 Docket # 2006P-0535

... 4. Exposure to vaccine level thimerosal crosses the blood brain barrier and results in significant deposition of inorganic mercury in the brain. 5. U.S policy is falling behind other countries on this important health issue and is not in keeping with the Institute of Medicine’s 2001 recommendations. ...
Vol 1   Pg 2 EXECUTIVE SUMMARY
Vol 1 Pg 2 EXECUTIVE SUMMARY

... factor for developing hepatotoxicity with therapeutic doses of acetaminophen. Based on available clinical science, stable chronic liver disease, in the presence or absence of alcohol, does not result in hepatotoxicity at maximum labeled daily doses of acetaminophen. Based on the body of scientific e ...
< 1 ... 27 28 29 30 31 32 33 34 35 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report